Cargando…
858. Impact of Using an Order Set on PrEP Prescribing and Laboratory Monitoring in Primary Care
BACKGROUND: CDC 2017 pre-exposure prophylaxis (PrEP) guideline recommends laboratory monitoring at baseline and follow-up and specifies that a PrEP prescription should be written for once daily dosing with a supply of 90 days or less to ensure patients repeat HIV testing every 3 months. This present...
Autores principales: | Dao, Linda T, Medders, Kathryn, Hill, Lucas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8644905/ http://dx.doi.org/10.1093/ofid/ofab466.1053 |
Ejemplares similares
-
981. Extended Adherence and Persistence to HIV PrEP in a Multidisciplinary PrEP Clinic
por: Whelchel, Kristen, et al.
Publicado: (2020) -
988. Overcoming Prescriber Concerns through Successful Access and Affordability of PrEP
por: Whelchel, Kristen, et al.
Publicado: (2020) -
850. Reasons for not Using PrEP and Actions that May Facilitate PrEP Uptake in Ontario and British Columbia, Canada
por: Espinosa, Oscar Javier Pico, et al.
Publicado: (2021) -
1319. Examining PrEP Knowledge and Prescribing Likelihood Among Medical Residents Before and After PrEP Education
por: Christian, Elizabeth, et al.
Publicado: (2018) -
973. PrEP Care Continuum among Transgender Women at a Patient-Centered PrEP Program in Atlanta, GA
por: Aldredge, Amalia, et al.
Publicado: (2020)